Announcement on Adjustment of Key Technical Personnel
Filed with SSE · · 3 pages · Chinese
Jiangsu Yahong Meditech Co., Ltd. on 6ix
Earlier from Jiangsu Yahong Meditech
- Announcement on Vesting Results of the 3rd Vesting Period of Those Initially Granted and the 2nd Vesting Period of Those Reserved for Grant in 2022 Restricted Stock Incentive Plan and Listing of Stocks
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resignation of Securities Affairs Representative
- Announcement on By-election of Directors
- Announcement on Resolutions of the 22nd Meeting of the 2nd Board of Directors
Later from Jiangsu Yahong Meditech
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on Receipt of Arbitration Notice
- Announcement on Arbitration Progress and Submission of Counter‑claim in Arbitration
- Announcement on Voluntary Disclosure of the FDA Approval of the APL-2501 Clinical Trial Application
- Jiangsu Asieris Pharmaceuticals Co., Ltd.: Announcement on Voluntary Disclosure of the Approval of the Clinical Trial Application for APL-2501 by the National Medical Products Administration
Follow Jiangsu Yahong Meditech into a list and get an email when it puts out news.
Follow Jiangsu Yahong Meditech